Notably, the increased ALT and AST levels in the DOX group were markedly reduced in both SXT- and ENP-treated groups (Figs. 1I and J), indicating that both SXT and ENP could alleviate DOX-induced liver dysfunction. This evidence concerns the gene GPT and Decreased liver function.